Gastroduodenal complications associated with non-steroidal anti-inflammatory drugs in Slovak Republic: Results of one-year prospective study;Podiel gastroduodenálnych komplikácií vo vzt'ahu k liečbe nesteroidovými antiflogistikami v Slovenskej republike: Ročná prospektívna štúdia

Vnitrni Lekarstvi

Volumn 52, Issue 7-8, 2006, Pages 673-676

  Rybár, Ivan ^a   Hlista M ^b   Masaryk, P ^c   Rovensky J ^a,c   Hyrdel, R ^d   Kriska M ^e  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b Chirurgické oddelenie NsP   (Slovakia)

^c NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^d II Interna Klinika JLF UK a Centrum Pre Liecbu Rezistentnych Peptickych Vredov   (Slovakia)

^e UK ^*  (Slovakia)

Author keywords

Epidemiology; Gastrointestinal bleeding; Gastropathy; Non steroidal anti inflammatory drugs; Peptic ulcer; Rheumatic diseases

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RHEUMATIC DISEASE; SLOVAKIA; UPPER GASTROINTESTINAL BLEEDING;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER;

EID: 33747749860     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Singh G. Recent consideration in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998; 105(Suppl 1): 31S-38S.
2. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and peroration associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.
3. Forrest JAH, Finlayson NDC, Shaerman DJC. Endoscopy in gastrointestinal bleeding. Lancet 1974; 326: 394-397.
4. Bures J. Gastric and duodenal ulcers - etiopathogenesis, diagnosis and therapy at the milestone of the 20th century. Vnitř Lék 2004; 50(Suppl 1): S91-S93.
5. Kunovská M, Dite P, Lata J et al. Helicobacter pylori negative gastroduodenal lesions in subjects treated with nonsteroidal anti-inflammatory drugs. Vnitř Lék 2000; 46: 384-386.
6. Fialová P, Vlček J. The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs. Vnitř Lék 2004; 50: 858-866.
7. Lukáš M, Chalupná P. Retrospektivní analýza vlivu nesteroidních antirevmatik na masivní krvácaní do horní části trávici trubice. Prakt Lék 2003; 83: 13-17.
8. Shostak NA, Riabkova AA, Saveljev VS et al. Gastrointestinal hemorrhages as complications of gastropathies associated with intake of nonsteroidal anti-inflammatory drugs. Ter Arkh 2003; 75: 70-73.
9. Wilcox CM, Shalek KA, Cotsonis G. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal haemorrhage. Arch Intern Med 1994; 154: 42-46.
10. Gutthann SP, Garcia Rodriguez LA, Raiford DS. Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 1997; 8: 18-24.